TO THE EDITOR Collagen XVII, also referred to as the 180 kDa bullous pemphigoid antigen (BP180), is a hemidesmosomal transmembrane protein targeted by autoreactive T and B cells in pemphigoid diseases, such as bullous pemphigoid (BP), pemphigoid gestationis, and mucous membrane pemphigoid (Sitaru and Zillikens, 2005; Mihai and Sitaru, 2007) . The pathogenicity of autoantibodies against collagen XVII is supported by extensive clinical and experimental evidence (Sitaru and Zillikens, 2005) . The membrane-proximal noncollagenous NC16A region of collagen XVII harbors both major pathogenic epitopes of the autoimmune response in BP and pemphigoid gestationis, and the proteolytic cleavage site(s) involved in the shedding of its 120 kDa extracellular domain (Giudice et al., 1993; Matsumura et al., 1996; Franzke et al., 2002) .
We recently showed that the NC16A domain is extracellularly phosphorylated by ecto-casein kinase 2 (CK2) at residue Ser 544 (Figure 1a ) and that phosphorylation of collagen XVII is functionally involved in the regulation of ectodomain shedding (Zimina et al., 2007) . Post-translational protein modifications, such as phosphorylation, have been shown to influence antigen recognition by autoantibodies in other autoimmune diseases, for example, multiple sclerosis or systemic lupus erythematosus (van Stipdonk et al., 1998; Doyle and Mamula, 2001; Anderton, 2004) . Therefore, it is of interest to assess the pathogenic relevance of post-translational modifications of collagen XVII in BP. In this study, we followed the hypothesis that phosphorylation of the immunodominant NC16A domain of collagen XVII alters the recognition by pemphigoid autoantibodies.
In the first set of experiments, we assessed phosphorylation of the ectodomain of collagen XVII in vitro and in vivo using an antibody (Ab) specific for ecto-phosphorylated collagen XVII, pSer 544 (Zimina et al., 2007) . This Ab immunoprecipitated collagen XVII ectodomain from the culture medium ( Figure 1b ), demonstrating that keratinocytes produce phosphorylated ectodomain. For immunoprecipitation, subconfluent normal human keratinocytes were cultured for 24 hours, and the medium was processed and precipitated as previously described (Schacke et al., 1998) . The proteins were dissolved in a lysis buffer containing 1% Nonidet P-40, 0.1 M NaCl, protease inhibitor set III (Calbiochem, Merck KGgA Darmstadt, Germany), phosphatase inhibitor cocktail 1 (Sigma-Aldrich, Taufkirchen, Germany), and 25 mM Tris-HCl at pH 7.4. The solution was then subjected to immunoprecipitation with the phospho-specific collagen XVII Abs pSer 544 overnight at 4 1C. After extensive washing, the proteins were eluted for 3 minutes at 95 1C with a buffer containing 0.8 M urea, 0.0001% bromphenol blue, 2% SDS, 5% glycerine, 0.01 M dithiothreitol, 0.1 M Tris-HCl, pH 6.8, and immunoblotted with NC16A-3 Abs (Seppanen et al., 2007) . In vivo, the ectodomain of collagen XVII was recovered from suction blisters (n ¼ 12) induced on normal healthy skin (Figure 1c , lower panel) and BP blisters (n ¼ 12, Figure 1d , lower panel) by immunoprecipitation with the mAb NC16A-1, which recognizes an epitope within the stretch of amino acid residues 513-525 (SC Hofmann et al., unpublished) . The phosphorylated form of the collagen XVII ectodomain was immunoprecipitated by pSer 544 from three suction blisters and five BP blisters ( Figure 1c and d, upper panels). For this, 200 ml of blister fluid were dialysed against phosphate-buffered saline using the Mini dialysis kit with 8 kDa MWCO (GE Healthcare, Munich, Germany) for 4 hours at 4 1C and subjected to immunoprecipitation with the Abs pSer544 and NC16A-1, as described above.
Although these data strongly suggest that the production of phosphorylated collagen XVII ectodomain is a physiological event in vivo, they do not rule out an involvement of autoantigen phosphorylation in the pathogenesis of BP. Collagen XVII phosphoepitopes colocalize with immunodominant epitopes of BP and PG within the NC16A domain supporting a role for phosphorylation in autoepitope recognition. To determine the impact of phosphorylation on the reactivity of BP sera with these epitopes, we compared the binding of circulating BP autoantibodies with phosphorylated and dephosphorylated collagen XVII. For this, subconfluent HaCaT cells were lysed and treated with l-phosphatase as described (Zimina et al., 2007) . Lysates were immunoblotted with polyclonal NC16A and monoclonal NC16A-3 Abs, anti-phospho MAPK p42/p44 Ab, and autoimmune sera of 16 BP patients. The sera were positive in ELISA for the immunodominant NC16A region (Hofmann et al., 2002) and in indirect immunofluorescence analysis for reactivity with collagen XVII. Semiquantitative densitometry was performed with the Gel-Pro Express 4.0 software (Media Cybernetics Inc., Marlow, UK). Interestingly, dephosphorylation of the extract resulted in a decrease of antigen recognition by 14/ 16 BP sera (Figure 2a and c, Figure S1 ). Seven serum samples exhibited a strong decrease in binding to collagen XVII and displayed only 10-20% of the initial reactivity. In case of further seven sera, the reactivity was reduced to 20-50% of the initial values. One serum sample showed a slightly diminished reactivity with dephosphorylated collagen XVII, and one serum sample showed no difference in the recognition of phosphorylated and dephosphorylated forms of collagen XVII (Figure 2c ).
Monoclonal and polyclonal Abs against the NC16A domain (Schumann et al., 2000; Seppanen et al., 2007) were used as controls; they did not show any difference in binding to phosphorylated or dephosphorylated forms of collagen XVII (Figure 2a ). The Ab pSer 544 specifically immunoprecipitated the phosphorylated form of collagen XVII (Figure 2b ). For immunoprecipitation, subconfluent HaCaT cells were lysed, treated with l-phosphatase as reported previously (Zimina et al., 2007) , and subjected to immunoprecipitation with the phospho-specific collagen XVII pSer 544 as described above. Serum samples of 20 healthy individuals were included as negative controls; they displayed no reactivity with either form of collagen XVII. Taken together, these observations suggest that BP autoantibodies preferentially recognize phosphorylated collagen XVII. This study demonstrates that synthesis of phosphorylated collagen XVII is a physiological event in vivo and that autoantibodies in a majority of BP patients preferentially recognize the phosphorylated ectodomain of collagen XVII. This observation is in line with investigations showing increased autoantibody reactivity with phosphorylated autoantigens in systemic lupus erythematosus (Satoh et al., 1994; Utz et al., 1997; Neugebauer et al., 2000; Terzoglou et al., 2006) . Phosphorylation of the systemic lupus erythematosus autoantigen La/SSB is catalyzed by intracellular CK2 and leads to higher recognition by autoantibodies (Terzoglou et al., 2006) . Ecto-CK2 is a key enzyme in the phosphorylation of collagen XVII (Zimina et al., 2007) . These findings further emphasize the importance of CK2-like activities in the generation of immunodominant epitopes in autoimmune diseases. However, the mechanisms leading to the breaking of self-tolerance in BP still remain unclear. Development of autoantigenicity may begin with the recognition of posttranslational modifications by T cells (Anderton, 2004) , and phosphorylation may create neo-epitopes (van Stipdonk et al., 1998) . Phosphorylation of the NC16A domain may contribute to the generation of autoantibodies against this region and thereby influence the pathogenesis of BP. It is tempting to speculate that a shift in the equilibrium of phosphorylated versus unphosphorylated collagen XVII ectodomain contributes to the initiation of the pathogenic autoimmune response(s) in BP. However, the possibility cannot be excluded that phosphorylation of collagen XVII ectodomain represents a compensatory mechanism to increase cell-matrix adhesion as a reaction to blistering induced by BP autoantibodies and that Figure S1 ). As an indicator for dephosphorylation efficiency, anti-phospho MAPK p42/p44 Ab was used. (b) The phosphoepitopespecific Ab pSer 544 specificallyP immunoprecipitates phosphorylated collagen XVII from keratinocyte extracts (left panel, arrow). ( þ P): before l-phosphatase treatment; (ÀP) after l-phosphatase treatment. Phosphatase treatment does not influence the amount of collagen XVII in HaCaT keratinocyte extract, as shown by immunoblotting with the mAb NC16A-3 (right panel). (c) Loss of phosphoepitopes in collagen XVII resulted in significantly decreased reactivity of 14/16 (88%) BP sera. The serum samples were tested on immunoblots as shown in panel a, and the intensity of the bands was quantitated by densitometry. The columns indicate the relative reactivity of the serum with dephosphorylated versus phosphorylated collagen XVII. the phosphoepitope Abs result from epitope spreading. A different constellation relevant in this context was investigated by Liu et al. (1993) who used passive transfer of Abs into mice to induce skin blistering. The Abs had been raised against recombinant prokaryotic non-phosphorylated NC16A fragments, and one could argue that phosphorylation is not required for blister formation. However, blister formation in the mouse model and the initiation of autoantigenicity in human disease may not be directly comparable, as other factors and mechanisms are most likely to influence the initial steps in the pathogenesis of human BP. Further investigations must clarify these questions. The study was conducted according to the Declaration of Helsinki Principles. Informed consent was obtained from the patients described in this paper.
